Case number 1:20-cv-20217
Merck Sharp & Dohme Corp. et al v. Actavis Laboratories FL, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 8, 2022 | 1 | Complaint* (1) |
| Feb 4, 2020 | 13 | Form AO 120/121 (1) |
| Feb 4, 2020 | 12 | Order Dismissing Case (1) |
| Feb 4, 2020 | 13 | Main Document (1) Docket Text: FORM AO 120 SENT TO DIRECTOR OF U.S. PATENT AND TRADEMARK (Attachments: # (1) Order) (mee) |
| Feb 4, 2020 | 12 | Order Dismissing/Closing Case (1) Docket Text: ORDER. Closing Case. Signed by Judge Ursula Ungaro on 2/4/2020. See attached document for full details. (mee) |
| Feb 4, 2020 | 13 | Order (1) |
| Feb 4, 2020 | 11 | Notice of Voluntary Dismissal (2) Docket Text: NOTICE of Voluntary Dismissal Without Prejudice by Cubist Pharmaceuticals LLC, MSD International GmbH, MSD Investment Holdings (Ireland), Merck Sharp & Dohme Corp., Optimer Pharmaceuticals LLC (Gillman, Stephen) |
| Jan 29, 2020 | 10 | Order Setting/Cancelling Hearing (3) Docket Text: ORDER SETTING INITIAL PLANNING AND SCHEDULING CONFERENCE (Scheduling Conference set for 3/13/2020 10:30 AM in Miami Division before Judge Ursula Ungaro, Joint Scheduling Report due by 2/28/2020) Signed by Judge Ursula Ungaro on 1/28/2020. See attached document for full details. (pcs) |
| Jan 21, 2020 | 9 | Summons Issued (3) Docket Text: Summons Issued as to All Defendants. (cbr) |
| Jan 17, 2020 | 1 | Complaint (31) |
| Jan 17, 2020 | N/A | Clerks Notice to Filer re: Electronic Case (0) |
| Jan 17, 2020 | 7 | Notice of Filing Proposed Summons(es) (1) |
| Jan 17, 2020 | 3 | Form AO 120/121 (1) |
| Jan 17, 2020 | 1 | Exhibit United States Patent 2011 (21) |
| Jan 17, 2020 | 5 | Certificate of Other Affiliates/Corporate Disclosure Statement (2) Docket Text: Plaintiff's Corporate Disclosure Statement by Cubist Pharmaceuticals LLC, MSD International GmbH, MSD Investment Holdings (Ireland), Merck Sharp & Dohme Corp., Optimer Pharmaceuticals LLC identifying Corporate Parent Merck & Co., Inc. for Cubist Pharmaceuticals LLC, MSD International GmbH, MSD Investment Holdings (Ireland), Merck Sharp & Dohme Corp., Optimer Pharmaceuticals LLC (Gillman, Stephen) |
| Jan 17, 2020 | 6 | Notice (Other) (1) Docket Text: NOTICE by Cubist Pharmaceuticals LLC, MSD International GmbH, MSD Investment Holdings (Ireland), Merck Sharp & Dohme Corp., Optimer Pharmaceuticals LLC re [1] Complaint,, [4] Clerks Notice to Filer re: Electronic Case Civil Cover Sheet (Gillman, Stephen) |
| Jan 17, 2020 | 7 | Summon(s) Actavis Laboratories (2) |
| Jan 17, 2020 | 3 | Complaint (181) |
| Jan 17, 2020 | 7 | Teva Pharmaceuticals (2) |
| Jan 17, 2020 | 8 | Bar Letter (3) Docket Text: Bar Letter re: Admissions sent to attorney Thomas D. Rein, Stephanie P. Koh, Gwen Hochman Stewart, Leif Peterson, Peter S. Choi, mailing date January 17, 2020, (pt) |
| Jan 17, 2020 | N/A | Clerk's Notice of Judge Assignment (0) Docket Text: Clerks Notice of Judge Assignment to Judge Ursula Ungaro. Pursuant to 28 USC 636(c), the parties are hereby notified that the U.S. Magistrate Judge John J. O'Sullivan is available to handle any or all proceedings in this case. If agreed, parties should complete and file the Consent form found on our website. It is not necessary to file a document indicating lack of consent. (mee) |
| Jan 17, 2020 | 1 | Exhibit New Jersey Complaint (35) |
| Jan 17, 2020 | 1 | Exhibit United States Patent 2014 (23) |
| Jan 17, 2020 | 1 | Exhibit United States Patent 2011 (24) |
| Jan 17, 2020 | 1 | Exhibit United States Patent 2008 (25) |
| Jan 17, 2020 | 1 | Main Document (31) Docket Text: COMPLAINT for Patent Infringement against All Defendants. Filing fees $ 400.00 receipt number 113C-12316485, filed by Optimer Pharmaceuticals LLC, Cubist Pharmaceuticals LLC, MSD Investment Holdings (Ireland), Merck Sharp & Dohme Corp., MSD International GmbH. (Attachments: # (1) Exhibit United States Patent 2011, # (2) Exhibit United States Patent 2013, # (3) Exhibit United States Patent 2008, # (4) Exhibit United States Patent 2011, # (5) Exhibit United States Patent 2014, # (6) Exhibit New Jersey Complaint)(Gillman, Stephen) |
| Jan 17, 2020 | 3 | Main Document (1) Docket Text: FORM AO 120 SENT TO DIRECTOR OF U.S. PATENT AND TRADEMARK (Attachments: # (1) Complaint) (mee) |
| Jan 17, 2020 | N/A | Clerk's Notice to Filer re: Electronic Case (0) Docket Text: Clerks Notice to Filer re: Electronic Case. No Civil Cover Sheet. Filer is instructed to file a Notice (Other) with the Civil Cover Sheet attached within 24 hours of the notice. (mee) |
| Jan 17, 2020 | 7 | Main Document (1) Docket Text: NOTICE of Filing Proposed Summons(es) by Cubist Pharmaceuticals LLC, MSD International GmbH, MSD Investment Holdings (Ireland), Merck Sharp & Dohme Corp., Optimer Pharmaceuticals LLC re [1] Complaint,, filed by Merck Sharp & Dohme Corp., Cubist Pharmaceuticals LLC, MSD International GmbH, Optimer Pharmaceuticals LLC, MSD Investment Holdings (Ireland) (Attachments: # (1) Summon(s) Actavis Laboratories, # (2) Summon(s) Actavis Pharma, # (3) Teva Pharmaceuticals) (Gillman, Stephen) |
| Jan 17, 2020 | 1 | Exhibit United States Patent 2013 (22) |
| Jan 17, 2020 | 7 | Summon(s) Actavis Pharma (2) |
